Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Zikani Therapeutics
480 Arsenal Way, Suite 130
Watertown, MA 02472
Phone: 617-453-9091
https://www.zikani.com/

Zikani Therapeutics is an emerging leader in the science of ribosome modulation, leveraging its innovative TURBO-ZMTM chemistry technology platform to develop novel Ribosome Modulating Agents (RMAs) as therapeutics for people with limited treatment options. Zikani's TURBO-ZMTM platform allows rapid synthesis of novel compounds that can be optimized to modulate the ribosome in a disease specific manner. As the company evolves its focus from early-stage to clinical-stage research, Zikani is actively moving into pre-clinical development to target select rare diseases including inherited diseases and cancers caused by nonsense mutations.

Key Contact
Name
Sumit Aggarwal
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
04/21/20 $7,500,000 Series A-1 Advent Life Sciences
Gurnet Point Capital
Roche Venture Fund
undisclosed


Featured Reading